Our Consortium

Meet Our Collaborative Network:
The Experts Behind EUCAIM

The EUCAIM consortium consist of 76 partners from 14 countries. Many partners are part of the “AI for Health Imaging” Network (AI4HI), a cluster of 5 large EU-funded projects on big data and AI in cancer imaging (CHAIMELEON, EUCANIMAGE, INCISIVE, ProCancer-I, PRIMAGE), whose data repositories EUCAIM is building on. The Consortium also involves major European Research Infrastructures, such as Euro-BioImaging, BBMRI, EATRIS and ELIXIR. Overall, in the EUCAIM consortium, public and private entities, many prestigious universities, private companies, and hospitals are represented to ensure that all of the necessary expertise are brought together for the success of EUCAIM.

Cyprus 🇨🇾

Czechia 🇨🇿

Finland 🇫🇮

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.